β2-Adrenergic receptor (β2-AR) agonist formoterol suppresses differentiation of L6 myogenic cells by blocking PI3K–AKT pathway
Open Access
- 2 January 2019
- journal article
- research article
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 23 (1) , 18-25
Abstract
β2-Adrenergic receptor (β2-AR) is implicated in muscle metabolic activities such as glycogen metabolism, glucose uptake, lipolysis and muscle growth. However, the functional role of β2-AR in the differentiation of skeletal muscle is largely unknown. Here, we examined the functional role of β2-AR in L6 myoblast differentiation using the long-term-acting β2-AR-specific agonist formoterol. We observed that formoterol treatment strongly suppressed L6 myoblast differentiation and the expression of myosin heavy chain (MHC) in a dose- and time-dependent manner. Showing that both long-acting agonist (formoterol) and short-acting agonist (terbutaline) inhibited the induction of MHC protein, whereas β2-AR antagonist (ICI-118,551) upregulated MHC expression, we clearly demonstrated that β2-AR is involved in L6 myoblast differentiation. Furthermore, our pharmacological inhibition study revealed that the PI3K–AKT pathway is the main signaling pathway for myotube formation. Formoterol inhibited the activation of PI3K–AKT signaling, but not that of ERK signaling. Moreover, formoterol selectively inhibited AKT activation by IGF-I, but not by insulin. Collectively, our findings reveal a previously undocumented role of β2-AR activation in modulating the differentiation of L6 myoblasts.Keywords
Funding Information
- 2-Year Research Grant of Pusan National University
This publication has 24 references indexed in Scilit:
- Modulation of β-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5Heart Failure Reviews, 2010
- Repairing skeletal muscle: regenerative potential of skeletal muscle stem cellsJournal of Clinical Investigation, 2010
- Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2DMolecular and Cellular Biology, 2008
- Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and DiseasePhysiological Reviews, 2008
- A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathwayOncogene, 2007
- L6 myoblast differentiation is modulated by Cdk5 via the PI3K–AKT–p70S6K signaling pathwayOncogene, 2004
- Skeletal muscle hypertrophy and anti‐atrophy effects of clenbuterol are mediated by the β2‐adrenergic receptorMuscle & Nerve, 2002
- Cyclic AMP Inhibits Akt Activity by Blocking the Membrane Localization of PDK1Journal of Biological Chemistry, 2001
- Insulin produces myogenesis in C2C12 myoblasts by induction of NF-?B and downregulation of AP-1 activitiesJournal of Cellular Physiology, 2000
- Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by AktScience, 1999